Page last updated: 2024-12-06
perillene
Description
Perillene is a monoterpene with the molecular formula C10H16. It is found in the essential oil of perilla (Perilla frutescens), a plant used in traditional medicine. Perillene has shown various biological activities, including antimicrobial, antioxidant, and anti-inflammatory properties. Its synthesis can be achieved through various methods, including chemical synthesis and extraction from natural sources. The study of perillene is important due to its potential applications in medicine, food, and cosmetics. Its antimicrobial activity has been investigated for its potential use in treating bacterial infections, while its antioxidant properties are being explored for their potential to prevent oxidative stress-related diseases. Research on perillene is ongoing to better understand its mechanisms of action and optimize its applications.'
perillene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
perillene : A monoterpenoid that is furan in which the hydrogen at position 3 is replaced by a 4-methylpent-3-en-1-yl group. A defensive allomone of thrips that has a flowery, citrus-like flavour. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 68316 |
| CHEBI ID | 74039 |
| SCHEMBL ID | 310752 |
| MeSH ID | M0239979 |
Synonyms (27)
| Synonym |
|---|
| 539-52-6 |
| perillen |
| furan, 3-(4-methyl-3-pentenyl)- |
| 3-(4-methylpent-3-enyl)furan |
| 3-(4-methyl-3-pentenyl)furan |
| unii-am4d4646zw |
| am4d4646zw , |
| perillene |
| 3-(4-methylpent-3-en-1-yl)furan |
| CHEBI:74039 |
| SCHEMBL310752 |
| 3-(4-methyl-3-pentenyl)-furan |
| XNGKCOFXDHYSGR-UHFFFAOYSA-N |
| 3-(4-methyl-3-pentenyl)furan # |
| DTXSID40202167 |
| AKOS028108563 |
| HY-N0827 |
| mfcd28387433 |
| Q15634089 |
| 3-(4-methyl-3-penten-1-yl)furan |
| furan, 3-(4-methyl-3-penten-1-yl)- |
| FT-0775721 |
| 3-isohexenylfuran |
| CS-0009859 |
| 3-(4-methyl-pent-3-enyl)-furan |
| A937649 |
| AS-82915 |
Roles (3)
| Role | Description |
|---|
| semiochemical | A molecular messenger released by an organism that affects the behaviour within or between species. |
| metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| fragrance | A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| furans | Compounds containing at least one furan ring. |
| monoterpenoid | Any terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 24.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 24.51 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 23.28 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |